Increased NRF2 expression has been observed in cervical CSCs [35], while increased expression of target genes of NRF2 was seen in breast CSCs [36], colon CSCs [37] and glioblastoma CSCs [38]. The gene discussed is NFE2L2; the disease is glioblastoma.